SEC Form 4 · accession 0001179110-17-007825
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ganesh Venkataraman Kaundinya
Officer — Senior V.P., Research
Period of report
May 19, 2017
Accepted (ET)
May 23, 2017 · 2:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | May 19, 2017 | S | 396 | $15.90 | D | 490,054 | D | |
| Common Stock | May 19, 2017 | S | 425 | $15.90 | D | 489,629 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 25, 2009.
- F2Reflects 3 additional shares sold by the Reporting Person on May 10, 2017 that were inadvertently not reported as sold in the Reporting Person's Form 4 filed on May 12, 2017.